Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.21 is 67% above its 5-year average of -9.67, near the high end of its 5-year range (-22.50–-0.82).
28.40% below its 12-month average of -2.50.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.64.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 36 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:51:08.021Z. Historical observations retain their original dates. Historical series through 2014-06-30.
EARNINGS PER SHARE (EPS)
-3.21
EARNINGS PER SHARE (EPS) AVG TTM
-2.50
EARNINGS PER SHARE (EPS) AVG 3Y
-4.25
EARNINGS PER SHARE (EPS) AVG 5Y
-9.67
EARNINGS PER SHARE (EPS) AVG 10Y
-2870.31
EARNINGS PER SHARE (EPS) AVG 15Y
-4159.25
EARNINGS PER SHARE (EPS) AVG 20Y
-25995.57
CURRENT VS TTM AVG
-28.40%
CURRENT VS 3Y AVG
+24.56%
CURRENT VS 5Y AVG
+66.81%
CURRENT VS 10Y AVG
+99.89%
CURRENT VS 15Y AVG
+99.92%
CURRENT VS 20Y AVG
+99.99%
CervoMed Inc.
Market Cap
$30.65M
Earnings Per Share (EPS)
-3.21
TTM Avg
-2.50
3Y Avg
-4.25
5Y Avg
-9.67
Market Cap
$30.92M
Earnings Per Share (EPS)
-0.48
TTM Avg
-0.42
3Y Avg
-0.82
5Y Avg
-1.14
Market Cap
$31.36M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.24
3Y Avg
-0.01
5Y Avg
0.39
Market Cap
$32.31M
Earnings Per Share (EPS)
-2.56
TTM Avg
-5.45
3Y Avg
-15.27
5Y Avg
-9.79
Market Cap
$32.32M
Earnings Per Share (EPS)
-0.17
TTM Avg
-0.24
3Y Avg
-0.47
5Y Avg
-0.92
Market Cap
$28.43M
Earnings Per Share (EPS)
-0.62
TTM Avg
-0.83
3Y Avg
-1.05
5Y Avg
-1.29
Market Cap
$33.42M
Earnings Per Share (EPS)
-7.30
TTM Avg
-11.70
3Y Avg
-7.29
5Y Avg
-5.93
Market Cap
$33.52M
Earnings Per Share (EPS)
-1.26
TTM Avg
-0.80
3Y Avg
-2.79
5Y Avg
-3.86
Market Cap
$27.31M
Earnings Per Share (EPS)
-4.31
TTM Avg
-4.75
3Y Avg
-350.99
5Y Avg
-43000.60
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CervoMed Inc. (CRVO) | $30.65M | -3.21 | -2.50 | -4.25 | -9.67 |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -0.48 | -0.42 | -0.82 | -1.14 |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | N/A | -0.24 | -0.01 | 0.39 |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -2.56 | -5.45 | -15.27 | -9.79 |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | -0.17 | -0.24 | -0.47 | -0.92 |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -0.62 | -0.83 | -1.05 | -1.29 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | -7.30 | -11.70 | -7.29 | -5.93 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | -1.26 | -0.80 | -2.79 | -3.86 |
| GridAI Technologies Corp. (GRDX)vs › | $27.31M | -4.31 | -4.75 | -350.99 | -43000.60 |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.48M | -0.29 | -0.41 | -1.95 | -2.99 |
Trailing EPS (TTM)
$-3.21
Forward EPS (Est.)
$-2.15
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.98 |
| 2024-12-31 | -2.02 |
| 2023-12-31 | -0.82 |
| 2022-12-31 | -11.20 |
| 2021-12-31 | -18.51 |
| 2020-12-31 | -22.50 |
| 2019-12-31 | -131.95 |
| 2018-12-31 | -424.93 |
| 2017-12-31 | -123.33 |
| 2016-12-31 | -1982.96 |
| 2015-12-31 | -28852.23 |
| 2014-12-31 | -11291.97 |
| 2013-12-31 | -11204.82 |
| 2012-12-31 | -93241.28 |
| 2011-12-31 | -295205.54 |
| 2010-12-31 | -150171.52 |
| 2009-12-31 | -66320.43 |
| 2008-12-31 | -42719.73 |
| 2007-12-31 | -61397.06 |
| 2006-12-31 | -456622.05 |
| 2005-12-31 | -900626.60 |
| 1999-12-31 | 0.00 |
| 1998-12-31 | 0.00 |
